LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Can Neurofilament Light Chain Be Utilized as a Biomarker of Disease Severity, Activity, and Outcomes in Anti-NMDA Receptor Encephalitis?

Photo from wikipedia

Anti-NMDA receptor encephalitis (anti-NMDARe) is a disorder characterized by a combination of behavioral, cognitive, and psychiatric alterations along with seizures, abnormal movements, dysautonomia, or a decreased level of consciousness that… Click to show full abstract

Anti-NMDA receptor encephalitis (anti-NMDARe) is a disorder characterized by a combination of behavioral, cognitive, and psychiatric alterations along with seizures, abnormal movements, dysautonomia, or a decreased level of consciousness that sequentially develop over several weeks in association with NMDAR-IgG in cerebrospinal fluid (CSF).1 This presentation is followed by weeks or months of persistent symptoms, often requiring intensive care (ICU), followed by a protracted recovery. Changes in CSF antibody titers may correlate with relapse, but serum titers are not reliable longitudinal biomarkers of disease activity.2

Keywords: nmda receptor; anti nmda; activity; receptor encephalitis

Journal Title: Neurology
Year Published: 2023

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.